Search inside this page
Publication dates
All regions
data types
Free Market Research Guides to Download
» Download Public Reports
1-30 of 35 reports
... Overview despite the global economic climate, position as a global leader in the quality, targeted radiation therapy for the cancer treatment and on delivering its technology in iba S business reports ...
... Driven by the increase in the company S stock price. Immunocellular therapeutics, ltd. Chief executive officer manish singh commented, We are pleased by the progress in our phase ii clinical trial ...
... Delivery qa as well as by the strong growth of radiation therapy in the bric countries. The company expects to show an improvement of its operational profitability over the next quarters as it has ...
... Drivers and restraints for influenza therapeutics market 6 generics in antivirals market to 2018 - major marketed drugs analysis /b> 6.1 Major generic drugs in antivirals market 6.1.1 Ribavirin 6 ...
... With non- seasonal sales (eg for dust mites or pet allergies) or those with sales that coincide with the allergy season. Source: allergy therapeutics, edison investment research allergy therapeutics ...
... For physiology or medicine. rnai therapeutics, such as "sirnas," require delivery technology to be effective systemically. Tekmira believes its lnp technology represents the most widely adopted delivery ...
... Inhibitor with potentially optimal risk/benefit balance providing consistent anticoagulation brivanib novel dual kinase inhibitor with broad anti-cancer potential establishing a new immunotherapy ...
... Management discussion section operator: good afternoon ladies and gentlemen and welcome to cytori therapeutics' first quarter earnings conference. Before we begin, we want to advice you that over ...
... Of obesity therapeutics and was a major participant in the recapitalization of orexigen (orex), an obesity therapeutics company, at $1.45 Per share in december 2011. He has developed deep relationships ...
... On disposal of bioassays business Following restructuring, iba equipment now operating as two segments, proton therapy / accelerators and dosimetry. Bioassays reclassified as Held for sale And excluded ...
... Tomography) and in cancer therapy (radiation therapy). In both applications, radiation is used to improve the outcome of the patient. However radiation has to be applied wisely and carefully in order ...
... Conversion rate of the existing backlog this quarter that is related to production planning and is not unusual for this type of activity. No new orders were signed in q1 for proton therapy projects ...
... For physiology or medicine. rnai therapeutics, such as "sirnas," require delivery technology to be effective systemically. Tekmira believes its lnp technology represents the most widely adopted delivery ...
... London, uk deutsche bank german & austrian corporate conference frankfurt, may 20-21, 2010 fresenius medical care the world S leading renal therapy company ...
... Care by focusing on overall cost of therapy and innovation organ support therapies and products for life saving treatments leading membrane technology business for adjacent extracorporeal ...
... Penetration in the german and northern european markets. The acquisition secures zoobiotic S position as the dominant player in the world larval therapy market. Zoobiotic S investors include partnerships (uk ...
... The eu should be amended to include the treatment of manic episodes in bipolar disorders when lithium is contraindicated or not tolerated. A question-and-answer document with more information about ...
... Outlook north america market outlook, north america Oncology remains a technology-driven industry Slow market recovery health insurance reform results in some opportunities, some risk Provider ...
... Development. Current competition in the tn market is weak globaldata S analysis suggested that the current competition in the tn therapeutics market is weak. The market has only one generic product, tegretol ...
... In global cns disorder therapeutics market as well as in each indication market. The report examines the global cns disorder treatment usage patterns. In addition, the geographical distribution of cns ...
... Series of treatment trials before effective therapies were found, if available. A personalized medicines approach offers opportunities to select drugs likely to be effective or safer, based on knowledge ...
... Portfolio and recent developments is also provided in the report. Transparency market research liver diseases therapeutics market - global industry analysis, size, share, trends ...
... Regionalized vaccination also implemented fmd main tools Mass vaccination (1) Delivery through public-private partnerships Quality control throughout vaccination chain vaccine production vaccine ...
... A measuring instrument for use in radiation therapy treatment of cancer. The measuring device automatically and safely measures exactly how much and where the radiation therapy treatment should be applied ...
... Increasing uptake of benlysta, uloric, krystexxa, and the launch of oral tofacitinib to spur growth. The report provides insights into the rheumatology therapeutics market forecasts until 2018 and examines ...
... Roche, amylin, novo-nordisk, ipsen and others. While cmos major players profiled are bachem, lonza, peptisyntha, polypeptide group and others. peptide therapeutics market, by applications cancer ...
... North american radiation oncology market elekta strategy jay hoey executive vice president region north america volume increases due to: aging baby boomers early detection ...
... Summary gbi research has found that the global dermatology therapeutics market is one of the more mature therapeutic markets in the pharmaceutical industry. Market revenue is only expected to increase ...
... Task force on major and chronic diseases the netherlands institute for health services research project output related to echi indicator lists december 2006 May 2007 ...
» Purchase Premium Reports (From $ 250 - $ 4 595)
About 3 300 reports
Peptide therapeutics is currently offering a new commercial potential to pharmaceuticals and biotechnology industry. To exploit this emerging market, large pharmaceutical and biotechnological firms are ...
Reportlinker.com © Copyright 2013. All rights reserved.